Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
Thomas Schnelldorfer(General Department of Preventive Medicine), Michael B. Farnell(Hudson Institute), David M. Nagorney(Mayo Clinic in Arizona), Michael G. Sarr(Mayo Clinic), Rachel E. Gullerud(Mayo Clinic), Lizhi Zhang(Dalian Maritime University), Rui Qin(Regeneron (United States)), Adam L. Ware(General Department of Preventive Medicine), John H. Donohue(Columbus Community Clinical Oncology Program), Thomas C. Smyrk(Mayo Clinic in Arizona)
Cited by 461
Related Papers
Risk Factors for Mortality After Surgery in Patients With Cirrhosis
|Gastroenterology|2007|571
Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study
|Journal of Clinical Oncology|2005|541
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Cellular Changes in Diabetic and Idiopathic Gastroparesis
|Gastroenterology|2011|445
Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional Approach
|Annals of Surgery|1994|389